T-cell prolymphocytic leukemia medical therapy: Difference between revisions
Jump to navigation
Jump to search
Carlos Lopez (talk | contribs) No edit summary |
Carlos Lopez (talk | contribs) |
||
| Line 8: | Line 8: | ||
==Medical Therapy== | ==Medical Therapy== | ||
T-cell prolymphocytic leukemia responds better when combinations of chemotherapy drugs are used. Some combinations that may be used are: | T-cell prolymphocytic leukemia responds better when combinations of chemotherapy drugs are used. Some combinations that may be used are:<ref name=T-PLL>{{cite web | title = Canadian Cancer Society| url =http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/prolymphocytic-leukemias/?region=on }}</ref> | ||
* CVP – [[Cyclophosphamide]], [[vincristine]] and [[prednisone]]. | * CVP – [[Cyclophosphamide]], [[vincristine]] and [[prednisone]]. | ||
| Line 18: | Line 18: | ||
* [[Fludarabine]] | * [[Fludarabine]] | ||
* [[Cladribine]] | * [[Cladribine]] | ||
* [[Pentostatin]] | * [[Pentostatin]] | ||
==References== | ==References== | ||
Revision as of 15:06, 30 September 2015
|
T-cell prolymphocytic leukemia Microchapters |
|
Differentiating T-cell Prolymphocytic Leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
T-cell prolymphocytic leukemia medical therapy On the Web |
|
American Roentgen Ray Society Images of T-cell prolymphocytic leukemia medical therapy |
|
Directions to Hospitals Treating T-cell prolymphocytic leukemia |
|
Risk calculators and risk factors for T-cell prolymphocytic leukemia medical therapy |
Overview
Medical Therapy
T-cell prolymphocytic leukemia responds better when combinations of chemotherapy drugs are used. Some combinations that may be used are:[1]
- CVP – Cyclophosphamide, vincristine and prednisone.
- CHOP – Cyclophosphamide, doxorubicin, vincristine and prednisone.
Other chemotherapy drugs (purine analogues) are often used to treat T-cell prolymphocytic leukemia are: